GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Emergent Biosolutions, Inc. (EBS) [hlAlert]

Rating:
Buy EBS
up 32.91 %

Cabot Stock of the Month picks Emergent (EBS) for 2009

Posted on: Saturday,  Feb 14, 2009  2:27 AM ET by The Stock Advisors Top Stocks For 2009

The Stock Advisors Top Stocks For 2009 rated Buy Emergent Biosolutions, Inc. (NYSE: EBS) on 01/08/2009, when the stock price was
$25.79. Since then, Emergent Biosolutions, Inc. has gained 32.92% as of 01/22/2016's recent price of $34.28.
If you would have followed this The Stock Advisors Top Stocks For 2009's recommendation on EBS, you would have gained 32.91% of your investment in 2570 days.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and immune-related therapeutics that assist the body?s immune system to prevent or treat disease. The Company develop vaccines and therapeutics for use against biological agents that are potential weapons of bioterrorism and biowarfare and infectious diseases that have resulted in significant unmet or underserved public health needs. It manufactures and markets BioThrax, also referred to as anthrax vaccine adsorbed, the only vaccine approved by the United States Food and Drug Administration (FDA), for the prevention of anthrax infection. BioThrax is approved for pre-exposure prevention of anthrax infection by all routes of exposure, including inhalation. In addition to the BioThrax product, the Company have product candidates in advanced stages of development and earlier stages of development.

Every year since 1983, thestockadvisors has polled the nation’s leading financial newsletter advisors asking them to select their favorite stocks for the coming year. In this year’s special report, 75 “best of breed” advisors have joined to provide you with the ultimate shopping list of trading and investing ideas for 2009. The stocks that are featured range from conservative, high quality blue chips to exciting home run speculations, for those willing to incur high risk in exchange for the potential to maximize upside gains. Importantly, readers should be certain that any stocks you consider meet your own investment strategy, time horizen and risk tolerance. As such, investors should view the 75 stocks in this report as a only as a starting place; do you own research, and continue to monitor any stocks that you may buy. Advisors are making their selections based on their current analysis of a company within the current market environment. But fundamentals change, and a stock that is now a favorite buy can quickly become a sell, based on future events.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2009 12:00 AM Buy
None
25.79
as of 12/31/2009
1 Week up  73.38 %
1 Month up  52.85 %
3 Months up  24.29 %
1 YTD down  -14.88 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy